These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29180903)

  • 1. Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution.
    Laugesen K; Støvring H; Hallas J; Pottegård A; Jørgensen JOL; Sørensen HT; Petersen I
    Clin Epidemiol; 2017; 9():591-600. PubMed ID: 29180903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):900-908. PubMed ID: 28466973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling.
    Bødkergaard K; Selmer RM; Hallas J; Kjerpeseth LJ; Pottegård A; Skovlund E; Støvring H
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1072-1078. PubMed ID: 32436295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining prescription durations based on the parametric waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1451-1459. PubMed ID: 27670969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating medication stopping fraction and real-time prevalence of drug use in pharmaco-epidemiologic databases. An application of the reverse waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):909-916. PubMed ID: 28474439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assigning exposure duration to single prescriptions by use of the waiting time distribution.
    Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):803-9. PubMed ID: 23703741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin.
    Thrane JM; Støvring H; Hellfritzsch M; Hallas J; Pottegård A
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1011-1018. PubMed ID: 29952049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations.
    Bødkergaard K; Selmer RM; Hallas J; Kjerpeseth LJ; Skovlund E; Støvring H
    Pharmacoepidemiol Drug Saf; 2021 Dec; 30(12):1727-1734. PubMed ID: 34382713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study.
    Pazzagli L; Andersen M; Sessa M
    Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):55-60. PubMed ID: 34611960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
    Fronstin P; Salisbury D; VanDerhei J
    EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of the Third Stage of Labor and Risk of Postpartum Hemorrhage.
    Frolova AI; Stout MJ; Tuuli MG; López JD; Macones GA; Cahill AG
    Obstet Gynecol; 2016 May; 127(5):951-956. PubMed ID: 27054942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the effect of current, previous and never use of drugs in studies based on prescription registries.
    Nielsen LH; Løkkegaard E; Andreasen AH; Hundrup YA; Keiding N
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):147-53. PubMed ID: 19072775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using prescription registries to define continuous drug use: how to fill gaps between prescriptions.
    Nielsen LH; Løkkegaard E; Andreasen AH; Keiding N
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):384-8. PubMed ID: 18213736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.
    Meaidi M; Støvring H; Rostgaard K; Torp-Pedersen C; Kragholm KH; Andersen M; Sessa M
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1805-1814. PubMed ID: 34247270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-admission use of glucocorticoids and 30-day mortality following colorectal cancer surgery: a population-based Danish cohort study.
    Ostenfeld EB; Erichsen R; Thorlacius-Ussing O; Riis AH; Sørensen HT
    Aliment Pharmacol Ther; 2014 Apr; 39(8):843-53. PubMed ID: 24611938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification.
    Riis AH; Johansen MB; Jacobsen JB; Brookhart MA; Stürmer T; Støvring H
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):478-85. PubMed ID: 25601142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Description of oral glucocorticoid prescriptions in general population].
    Fardet L; Petersen I; Nazareth I
    Rev Med Interne; 2011 Oct; 32(10):594-9. PubMed ID: 21420765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
    Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
    JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study.
    Spoendlin J; Meier C; Jick SS; Meier CR
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1116-1123. PubMed ID: 27297005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.